Catalent - Asia-Pacific clinical packaging facilities
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

27

May 2020

Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb

Repare Therapeutics Inc Repare a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in genetically defined patient populations today announced it has entered into an exclusive worldwide research collaboration with Br...

27

May 2020

ArcherDX Announces Strategic Collaboration with AstraZeneca

ArcherDX Inc announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase clinical trials for AstraZenecas targeted immunooncology therapeutics

26

May 2020

Oncodesign and HitGen Announce a Strategic Partnership in Integrated Drug Discovery Services (IDDS)

ONCODESIGN announced the start of a worldwide strategic alliance in Integrated Drug Discovery Services for the identification and progression of new chemical entities spanning from Hit finding up to preparation of the Investigational New Drug filing

26

May 2020

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies

Tavotek Biotherapeutics a biotech company which develops novel biologics for autoimmune diseases and oncology announced that it has entered into a research agreement with Genmab AS of Denmark to create and develop bispecific antibodies using Genmabs DuoBody technology platform against disease releva...

25

May 2020

FDA approves Takeda's ALUNBRIG ® (brigatinib) as a first-line treatment for patients with rare and severe forms of lung cancer

Takeda Pharmaceutical Company Limited TSE NYSE TAK announced today that the US Food and Drug Administration FDA is approved for ALUNBRIG Brigatinib for adult patients with anaplastic lymphoma kinase ALK positive metastatic nonsmall cell lung cancer NSCLC which was diagnosed by an FDAapproved test...

23

May 2020

AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly

AbCellera announced that it has entered into a multiyear strategic research collaboration and license agreement with Eli Lilly and Company Lilly on the discovery of antibodies for up to nine Lillyselected therapeutic targets Lilly will have the rights to develop and commercialize therapeutic product...

22

May 2020

Kleo Pharmaceuticals and Celularity Enter into Research Collaboration

Kleo Pharmaceuticals Inc a leading company in the field of developing nextgeneration fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics and Celularity Inc a leading developer of allogeneic or offtheshelf natural killer NK cell therapies today announced a pr...

press releasesRead more...

27

May 2020

Protara Therapeutics Receives Fast Track Designation from U.S. FDA for Intravenous Choline Chloride for the Treatment of Intestinal Failure Associated Liver Disease

Protara Therapeutics Inc a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs announced that the US Food and Drug Administration FDA has granted Fast Track designation to Intravenous IV Choline Chloride for the treatment of intestinal failureass...

27

May 2020

Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

Ceapro Inc a growthstage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries today announced it has entered into an additional research project expanding on the ongoing collaboration with McMaster University to develop a...

26

May 2020

SeraNovo Enters into a Second License Agreement with Carna Biosciences for Development of Oral Formulation of Carna’s Kinase Inhibitor

SeraNovo BV announced that it has signed a second License Agreement with Carna Biosciences Inc a company engaged in the drug development of kinase inhibitors Under the agreement the companies will expand their existing collaboration and jointly develop an oral formulation of a new active ingredient...

26

May 2020

Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology autoimmune metabolic and other major diseases today announced that the first patient has been successfully dosed in a Phase clinical trial...

25

May 2020

Algernon Submits Investigational New Drug (IND) Application with U.S. FDA for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil for COVID-19

Algernon Pharmaceuticals Inc a clinical stage pharmaceutical development company is pleased to announce that it has submitted an Investigational New Drug IND application with the US FDA for its planned multinational Phase b study of its repurposed drug NP Ifenprodil as a potential therapeutic treatm...

23

May 2020

Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia

Zealand Pharma AS a biotechnology company changing lives with innovative peptidebased medicines announced that the US Food and Drug Administration FDA has accepted for filing the companys New Drug Application NDA for the dasiglucagon HypoPal Rescue Pen for the treatment of hypoglycemia in people wi...

22

May 2020

Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Approval

Aquestive Therapeutics Inc a pharmaceutical company focused on developing and commercializing differentiated products that address patients unmet needs and solve therapeutic problems today announced plans to advance its strategy to monetize the anticipated royalties associated with Sunovion Pharmace...

EventsRead more...

27 - 28

May 2020

28 - 28

May 2020

11th Annual Clinical Trials Summit 2020

Virtue Insight
Kohinoor Continental Hotel

02 - 22

Jun 2020

03 - 04

Jun 2020

Parkinson's and Movement Disorders

Pulsus Conference
Vienna

08 - 09

Jun 2020

10 - 11

Jun 2020

15 - 17

Jun 2020

TOP ARTICLES

KNOWLEDGE BANK

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...